Background: Lack of first phase insulin secretion during oral glucose tolerance test [OGTT] in Type 2 Diabetes Mellitus (DM) is attributed to glucose toxicity. Alternatively, the role of insulin resistance in impaired insulin release secondary to lack of glucose entry into β cells may be responsible, but is not examined. Aim: The role of insulin sensitivity in 1st phase insulin secretion was assessed. Material and Methods: Plasma glucose (G) and insulin (I) concentrations were determined after an overnight fast (F) and upto 60 minutes during OGTT with glucose 75g in 12 normal (N), 14 with impaired glucose tolerance (IGT) and 41 subjects with Type 2 DM. First phase insulin secretion (Δ Insulin) was determined as a percentage rise from baseline 100x (Peak-Basal)/Basal. Insulin sensitivity was determined as FI x FG (mUxmM/L). Results: FG were normal (< 5.5 mM/L) in both N and IGT; and >7.0 mM/L in Type 2 DM. FI x FG and ? insulin were 35 ± 4 and 389 ± 89% in N; 77 ± 5 and 254 ± 65% in IGT; and 235 ± 19 and 95 ± 15% in Type 2 DM. Significant negative correlations were noted between ? insulin one hand and FI x FG on the other amongst all subjects [p < 0.0001 for all correlations]. Conclusion: Decline of 1st phase insulin secretion in IGT and Type 2 DM may be attributed to inhibited release of depleted insulin stores in the β Cells induced by impaired glucose entry due to insulin resistance, and is unlikely to be caused by glucose toxicity in IGT in presence of fasting euglycemia.
Weyer, C., Bogardus, C., Mott, D.M. and Pratley, R.E. (1999) The natural history of insulin secretary dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. The Journal of Clinical Investigation, 104, 787-794. doi:10.1172/JCI7231
Ward, W.K., Beard, J.C., Halter, J.B., Pfeifer, M.A. and Porte, D. (1984). Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care, 7, 491-502. doi:10.2337/diacare.7.5.491
Grodsky, G.M. (1989) A new phase of insulin secretion. How will it contribute to our understanding of beta-cell function? Diabetes, 38, 673-678. doi:10.2337/diabetes.38.6.673
Dinneen, S., Gerich, J. and Rizza, R. (1992) Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 327, 707- 713.
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reily, J. and Gerich, J. (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. The New England Journal of Medicine, 326, 22-29. doi:10.1056/NEJM199201023260104
Van Haeften, T.W., Pimenta, W., Mitrakou, A., Koryti- kowski, M., Jenssen, T., Yki-Jarvinen, H. and Gerich, J.E. (2000) Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism, 49, 1318-1325. doi:10.1053/meta.2000.9526
Bruce, D.G., Chisholm, D.J., Storlien, L.H. and Kraegen, E.W. (1988). Physiological importance of deficiency in early prandial insulin secretion in non-insulin dependent diabetes. Diabetes, 37, 736-744. doi:10.2337/diabetes.37.6.736
Rossetti, L., Giaccari, A. and DeFronzo, R.A. (1990) Glucose toxicity. Diabetes Care, 13, 610-630. doi:10.2337/diacare.13.6.610
Flax, H., Matthews, D.R., Levy, J.C., Coppack, S.W., Turner, R.C. (1991) No glucotoxicity after 53 hours of 6.0mmol/l hyperglycaemia in normal man. Diabetologia, 34, 570- 575. doi:10.1007/BF00400275
American Diabetes Association, (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care. 29, S43-S48.
Kabadi, U.M. and Einstein, A.B. (1980). Glucose intolerance in hyperthyroidism: Role of glucagons. The Jour- nal of Clinical Endocrinology & Metabolism, 50, 392- 396. doi:10.1210/jcem-50-2-392
Matsuda, M. and Defronzo, R. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care, 22, 1462-1470. doi:10.2337/diacare.22.9.1462
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Jarvinen, H., Van Haeften, T., Renn, W. and Gerich, J. (2000). Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 23, 295-301. doi:10.2337/diacare.23.3.295
Kanauchi, M., Yamano, S., Kanauchi, K. and Yoshihiko, S. (2003). Homeostasis ModelAssessment of Insulin Resistance, Quantitative Insulin Sensitivity CheckIndex and Oral Glucose Insulin Sensitivity Index in Nonobese, Nondiabetic Subjects with High-Normal Blood Pressure. The Journal of Clinical Endocrinology & Metabolism, 88, 3444-3446. doi:10.1210/jc.2002-021641
Clarke, N., Sivitz, W. and Kabadi, U. (2005) Product of fasting plasma glucose and fasting plasma insulin: A simple and reliable index of insulin sensitivity. Diabetes Research, 39, 25-31.
Abdul-Ghani, M.A., Tripathy, D., Jenckinson, C., Ritchardson, D. and DeFronzo, R.A. (2006). Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study (VEGAS). Diabetes, 55, 1430-1435. doi:10.2337/db05-1200
Kahn, S.E. (2003) The relative contributions of insulin resistance and B-cell dysfunction to the pathophysiology of type 2 diabetes mellitus. Diabetologia, 46, 3-19.
Wasada, T., Kuroki, H., Katsumori, K., Arii, H,. Sato, A., Aoki, K., Jimba, S. and Hanai, G. (2004). Who are more insulin resistant, people with IFG or people with IGT? Diabetologia; 47, 758-759.
Festa, A., D’Agostino, R., Hanley, A.J., Karter, A.J., Saad, M.F. and Haffner, S.M. (2004). Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes; 53, 1549-1555. doi:10.2337/diabetes.53.6.1549
Osei, K., Gaillard, T. and Schuster, D.P. (1997). Pathogenetic mechanisms of impaired Glucose tolerance and type II diabetes in African Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care, 20, 396-404. doi:10.2337/diacare.20.3.396
Pimenta, W.P., Santos, M.L., Cruz, N.S., Aragon, F.F., Padovani, C.R. and Gerich, J.E. (2002). Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion. Diabetes & metabolism, 28, 468-476.
Carnevale Schianca, G.P., Rossi, A., Sainaghi, P.P., Maduli, E. and Cartoli, E. (2003). The significance of impaired fasting glucose versus impaired glucose tolerance: Importance of insulin secretion and resistance. Diabetes Care; 26, 1333-1337. doi:10.2337/diacare.26.5.1333
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A. and DeFronzo, R.A. (2005) B-cell function in subjects spanning the range from normal glucose Tolerance to overt diabetes: A new analysis. The Journal of Clinical Endocrinology & Metabolism, 90, 493-500.
Abdul-Ghani, M.A., Sabbah, M., Kher, J., Minuchin, O., Vardi, P. and Raz, I. (2006). Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli arabs with IFG and IGT. Diabetes/Metabolism Research and Reviews, 22, 126-130. doi:10.1002/dmrr.595
Abdul-Ghani, M.A., Tripathy, D. and DeFronzo, R.A. (2006). Contributions of β-cell dysfunction and insulin reistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care, 29, 1130-1138. doi:10.2337/dc05-2179
Pfeifer, M.A., Halter, J.B. and Porte, D.J. (1981). Insulin secretion in diabetes mellitus. The American Journal Medicine, 70, 579-588. doi:10.1016/0002-9343(81)90579-9
World Health Organization (1985). Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization.
Bergman, R.N., Finegood, D.T., Kahn, S.E. (2002). The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. The European Journal of Clinical Investigation, 32, 35-45. doi:10.1046/j.1365-2362.32.s3.5.x
Orci, L., Unger, R.H., Ravazzola, M., Ogawa, A., Komiya, I., Baetens, D., Lodish, H.F. and Thorens, B. (1990). Reduced beta-cell glucose transporter in new onset diabetic BB rats. The Journal of Clinical Investigation, 86, 1615-1622. doi:10.1172/JCI114883
Brant, A.M., McCoid, S., Thomas, H.M., Baldwin, S.A., Davies, A., Parker, J.C., Gibbs, E.M. and Gould, G.W. (1992). Analysis of the glucose transporter content of islet cell lines: Implications for glucose-stimulated insulin release. Cellular Signaling, 4, 641-650. doi:10.1016/0898-6568(92)90045-A
Girard, J., Postic, C., Burcelin, R., Guillet, I. and Letur- que, A. (1992) Glucose Transporters. Physiology and physiopathology. Presse Medicale, 21, 2053-2059.
Hughes, S.D., Quaade, C., Johnson, J.H., Ferber, S., and Newgard, C.B. (1993). Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose -stimulated insulin secretion. Relationship to glucose metabolism. The Journal of Biological Chemistry, 268, 15205-15212.
Valera, A., Solanes, G., Fernandez-Alvarez, J., Pujol, A., Ferrer, J., Asins, G., Gomis, R. and Bosch, F. (1994). Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes. The Journal of Biological Chemistry, 269, 28543-28546.
Wang, M.Y., Koyama, K., Shimabukuro, M., Mangelsdorf, D., Newgard, C.B. and Unger, R.H. (1998) Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proceedings of the National Academy of Sciences of the United States of Americ, 95, 11921-11926. doi:10.1073/pnas.95.20.11921
Lopes Da Costa, C., Sampaio De Freitas, M. and Sanch- ez Moura, A. (2004) Insulin secretion and GLUT-2 expression in undernourished neonate rats. The Journal of Nutritional Biochemistry, 15, 236-241. doi:10.1016/j.jnutbio.2003.12.004
Daniel, S., Noda, M., Straub, S.G. and Sharp, G.W. (1999) Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes, 48, 1686-1690. doi:10.2337/diabetes.48.9.1686